Skip to main content
Polaris Group logo

Polaris Group — Investor Relations & Filings

Ticker · 6550 ISIN · KYG7171A1085 TW Manufacturing
Open in API
Filings indexed 46 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 6550

About Polaris Group

https://www.polarispharma.com

Polaris Group is a biotechnology company dedicated to the development of novel anti-cancer therapies and the provision of Contract Development and Manufacturing Organization (CDMO) services. The company’s core research focuses on ADI-PEG 20 (pegargiminase), a biological agent that utilizes metabolic therapy to target arginine-dependent cancers. This candidate is currently in late-stage clinical development for multiple indications, including mesothelioma, soft tissue sarcoma, and hepatocellular carcinoma. Polaris Group maintains a vertically integrated business model, encompassing drug design, clinical trial management, and internal manufacturing capabilities. It operates cGMP-compliant facilities and has expanded its CDMO portfolio to include complex injectables and synthetic peptides. The company aims to deliver innovative treatment options by leveraging its proprietary technology and global clinical partnerships.

Recent filings

Filing Released Lang Actions
公告本公司115年第一季合併財務報告董事會召開日期
Regulatory Filings
2026-05-04 Chinese
114年年報及股東會資料 — 2025_6550_20251226F05.pdf
Share Issue/Capital Change Classification · 88% confidence The document is the formal minutes (議事錄) of an extraordinary shareholders meeting of Polaris Group held on 26 December, where the sole agenda was to approve a private placement of up to 150 million new common shares to raise operating funds and repay bank debt. It includes detailed capital increase terms, subscriber criteria, pricing methodology, board authorizations, and actual voting results. This is clearly a notice of a share issuance and capital structure change, matching the definition for Share Issue/Capital Change (Code: SHA).
2026-04-24 Chinese
114年年報及股東會資料 — 2025_6550_20251226FE1.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an extraordinary general meeting of shareholders, including information on the meeting agenda, proxy forms, voting methods, and solicitation details. This matches the definition of ‘Proxy Solicitation & Information Statement (PSI)’—materials sent to shareholders to provide information and request votes for meetings. It is not a full annual report, regulatory filing, or vote result announcement.
2026-04-24 English
114年年報及股東會資料 — 2025_6550_20251226F01.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a shareholders’ meeting notice and information statement detailing a proposed private placement of common shares (up to 150,000,000 shares), the pricing rationale, selection of specific investors, and requests for shareholder authorization of the board to implement the plan. It includes attendance cards and underwriter opinion letters as attachments, all of which are typical proxy solicitation materials provided to shareholders in advance of a general meeting. This matches the Proxy Solicitation & Information Statement category.
2026-04-24 Chinese
114年年報及股東會資料 — 2025_6550_20251226F13.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is the full agenda and discussion materials (“議事手冊”) for Polaris’s 114th year second Extraordinary Shareholders Meeting. It contains the detailed proposal for a private placement of common shares, background, rationale, underwriter opinion, attachments (company constitution, shareholding tables, financial statements), and is clearly aimed at soliciting shareholder approval and votes at the meeting. This is not an earnings release, legal notice, transcript or simple announcement; it is the comprehensive information statement/proxy materials sent to shareholders for voting on the proposal. Therefore it falls under Proxy Solicitation & Information Statement (Code: PSI).
2026-04-24 English
114年年報及股東會資料 — 2025_6550_20251226FE2.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled as a “Handbook for the 2025 Second Extraordinary Meeting of Shareholders,” containing detailed agenda items, proposals (private placement of shares), resolutions, appendices (evaluation report, Articles of Incorporation, rules of procedure, shareholding tables), and meeting materials supplied to shareholders for voting. Such comprehensive meeting materials to inform and solicit shareholder votes correspond to “Proxy Solicitation & Information Statement” (PSI), rather than an actual annual or interim report or simple announcement.
2026-04-24 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.